Position in VTRS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$563,692
-$77,364,054 QoQ
Shares Held
35,497
-99.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#392
of 1,016 holders
Holding Since
Mar 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JUPITER ASSET MANAGEMENT LTD holds $164,709,425 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
4,219,279 | $103,836,455 | |
| 2 | ZTS |
Zoetis Inc.
|
429,356 | $30,853,522 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,642,874 | $16,428,740 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
197,149 | $8,089,022 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
274,944 | $4,937,994 | |
| 6 | VTRS |
Viatris Inc
This page
|
35,497 | $563,692 |
All Filings in VTRS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $563,692 | 35,497 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $77,927,746 | 5,768,153 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $48,670,834 | 3,909,304 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $31,187,840 | 3,150,287 | Shares | Defined | 2025-11-10 | |
| 2022-03-31 | $3,490,717 | 320,838 | Shares | Defined | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||